Nisa Investment Advisors’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $7.92K | Buy |
695
+96
| +16% | +$1.09K | ﹤0.01% | 2353 |
|
2025
Q1 | $7.12K | Sell |
599
-24
| -4% | -$285 | ﹤0.01% | 2178 |
|
2024
Q4 | $11.7K | Sell |
623
-59
| -9% | -$1.11K | ﹤0.01% | 2092 |
|
2024
Q3 | $15.3K | Buy |
682
+59
| +9% | +$1.33K | ﹤0.01% | 1990 |
|
2024
Q2 | $13K | Buy |
623
+524
| +529% | +$10.9K | ﹤0.01% | 2070 |
|
2024
Q1 | $1.46K | Buy |
99
+74
| +296% | +$1.09K | ﹤0.01% | 2289 |
|
2023
Q4 | $258 | Sell |
25
-1,240
| -98% | -$12.8K | ﹤0.01% | 2518 |
|
2023
Q3 | $9.94K | Buy |
1,265
+1,221
| +2,775% | +$9.6K | ﹤0.01% | 2179 |
|
2023
Q2 | $440 | Buy |
+44
| New | +$440 | ﹤0.01% | 2584 |
|
2023
Q1 | – | Sell |
-2,250
| Closed | -$25K | – | 2639 |
|
2022
Q4 | $25K | Hold |
2,250
| – | – | ﹤0.01% | 1997 |
|
2022
Q3 | $29K | Buy |
2,250
+50
| +2% | +$644 | ﹤0.01% | 1943 |
|
2022
Q2 | $28K | Sell |
2,200
-20,600
| -90% | -$262K | ﹤0.01% | 1940 |
|
2022
Q1 | $319K | Buy |
+22,800
| New | +$319K | ﹤0.01% | 1214 |
|